Vanderbilt Brain Institute
-
New target identified for rapid antidepressant drugs
THE IDEA Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. Ege Kavalali (Vanderbilt University) Lisa Monteggia (John Russell/Vanderbilt University) The research was led by… Read MoreNov. 10, 2021